Who owns NEUROPACE INC?
- Ticker: NPCE
- CUSIP Number: 641288105
Tip: Access positions for across all investors
Analyze quarterly positions in Neuropace with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neuropace stock
Who bought or sold NEUROPACE INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 3.4M | $24M | 0% | Sep 2024 |
|
| Morgan Stanley | 2.5M | $19M | -1% | Jun 2024 |
|
| Soleus Capital Management | 2.4M | $18M | 0% | Jun 2024 |
|
| Kent Lake PR | 1.3M | $8.7M | 100% | Sep 2024 |
|
| Kent Lake Capital | 1.1M | $8.7M | 78% | Jun 2024 |
|
| Vanguard Group | 968k | $7.3M | 98% | Jun 2024 |
|
| BlackRock | 705k | $4.9M | 100% | Sep 2024 |
|
| BlackRock | 671k | $5.1M | 805% | Jun 2024 |
|
| Nantahala Capital Management | 608k | $4.2M | -1% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 412k | $2.9M | -37% | Sep 2024 |
|
| Geode Capital Management | 317k | $2.2M | 9% | Sep 2024 |
|
| Northern Trust | 160k | $1.1M | 440% | Sep 2024 |
|
| State Street Corporation | 143k | $1.1M | 283% | Jun 2024 |
|
| Renaissance Technologies | 87k | $606k | 7% | Sep 2024 |
|
| Charles Schwab Investment Management | 37k | $255k | 0% | Sep 2024 |
|
| Bridgeway Capital Management | 33k | $251k | 0% | Jun 2024 |
|
| Two Sigma Investments | 33k | $250k | 100% | Jun 2024 |
|
| Bank of New York Mellon | 24k | $169k | -29% | Sep 2024 |
|
| Goldman Sachs Group | 24k | $181k | -83% | Jun 2024 |
|
| Barclays | 21k | $144k | 346% | Sep 2024 |
|
| Nuveen Asset Management | 18k | $139k | 100% | Jun 2024 |
|
| Financial Advocates Investment Management | 18k | $126k | 20% | Sep 2024 |
|
| Citadel Advisors | 18k | $125k | -61% | Sep 2024 |
|
| Rhumbline Advisers | 14k | $100k | -2% | Sep 2024 |
|
| Bank of America Corporation | 13k | $93k | -23% | Sep 2024 |
|
| Alpine Partners VI | 13k | $98k | 100% | Jun 2024 |
|
| Jpmorgan Chase & Co | 12k | $84k | 106% | Sep 2024 |
|
| Citigroup | 9.8k | $69k | 232% | Sep 2024 |
|
| Qube Research & Technologies | 8.8k | $67k | -80% | Jun 2024 |
|
| Mitsubishi UFJ Asset Management | 8.8k | $61k | 100% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 7.5k | $52k | 100% | Sep 2024 |
|
| Tower Research Capital | 4.4k | $33k | 17% | Jun 2024 |
|
| Wells Fargo & Company | 4.2k | $29k | -34% | Sep 2024 |
|
| Acadian Asset Management | 3.6k | $24k | -95% | Sep 2024 |
|
| Lazard Asset Management | 3.4k | $23k | 0% | Sep 2024 |
|
| HighMark Wealth Management | 3.0k | $21k | 100% | Sep 2024 |
|
| Royal Bank of Canada | 1.8k | $14k | 42% | Sep 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 1.8k | $12k | 100% | Sep 2024 |
|
| Summit Investment Advisors | 1.3k | $9.3k | 0% | Sep 2024 |
|
| Jones Financial Companies, L.L | 1.0k | $6.7k | 100% | Sep 2024 |
|
| California State Teachers Retirement System | 989.00 | $6.9k | 0% | Sep 2024 |
|
| New York State Common Retirement Fund | 900.00 | $6.0k | -94% | Sep 2024 |
|
| Amalgamated Bank | 472.00 | $3.0k | 0% | Sep 2024 |
|
| CWM | 179.00 | $1.0k | 8% | Sep 2024 |
|
| NISA Investment Advisors | 53.00 | $369.001900 | 100% | Sep 2024 |
|
| Sterling Capital Management | 14.00 | $98.000000 | 100% | Sep 2024 |
|
Who sold out of Neuropace?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2024 | 686k | $5.2M |
| Man Group | Jun 2024 | 39k | $291k |
| Marshall Wace | Jun 2024 | 32k | $242k |
| Balyasny Asset Management | Mar 2024 | 27k | $356k |
| XTX Topco | Jun 2024 | 24k | $182k |
| Petrus Trust Company | Mar 2024 | 24k | $316k |
| Susquehanna International | Jun 2024 | 20k | $150k |
| ExodusPoint Capital Management | Mar 2024 | 19k | $256k |
| Squarepoint Ops | Mar 2024 | 13k | $176k |
| Cubist Systematic Strategies | Jun 2024 | 12k | $87k |
| Jump Financial | Jun 2024 | 11k | $86k |
| Leucadia National Corporation | Mar 2024 | 11k | $144k |
| Macquarie Group | Mar 2024 | 1.2k | $16.053200 |
| Simplex Trading | Jun 2024 | 370.00 | $2.0k |